论文部分内容阅读
目的研究25+微创玻璃体视网膜手术治疗孔源性视网膜脱离的临床效果。方法回顾性分析孔源性视网膜脱离患者52例(52眼),治疗组(n=26)行25+微创玻璃体视网膜手术,对照组(n=26)行23G微创玻璃体视网膜手术。分析两组患者手术时间、术后视力、眼压、并发症和视网膜复位情况。结果与对照组比较,治疗组手术时间缩短(P<0.05);术后3 d及术后7 d,两组患者眼压较术前均升高,最佳矫正视力的最小分辨角对数均降低(P<0.05);术中治疗组并发症发生率(15.38%)低于对照组(42.31%)(P<0.05);术后治疗组低眼压发生率(3.85%)低于对照组(30.77%)(P<0.05);治疗组视网膜复位率(92.31%)与对照组(88.46%)比较差异无统计学意义(P>0.05)。结论 25+与23G微创玻璃体视网膜手术治疗孔源性视网膜脱离的临床效果相当,但25+微创玻璃体视网膜手术能有效减少术中并发症及术后低眼压的发生,具有更高的安全性。
Objective To study the clinical effect of 25 + minimally invasive vitreoretinal surgery for rhegmatogenous retinal detachment. Methods 52 patients (52 eyes) with rhegmatogenous retinal detachment were retrospectively analyzed. Twenty-five minimally invasive vitreoretinal surgery in the treatment group (n = 26) and 23G minimally invasive vitreoretinal surgery in the control group (n = 26) were performed. The operation time, postoperative visual acuity, intraocular pressure, complications and retinal reattachment were analyzed. Results Compared with the control group, the operation time of the treatment group was shorter (P <0.05); at 3 days and 7 days after operation, the intraocular pressure in both groups were significantly higher than those before operation, and the minimum resolution angle of best corrected visual acuity (P <0.05). The incidence of intraoperative complications (15.38%) was lower than that of the control group (42.31%) (P <0.05). The incidence of postoperative hypotension (3.85%) in the treatment group was lower than that in the control group (30.77%) (P <0.05). The retinal reattachment rate in the treatment group (92.31%) was not significantly different from that in the control group (88.46%) (P> 0.05). Conclusion 25 + and 23G minimally invasive vitreoretinal surgery for the treatment of rhegmatogenous retinal detachment clinical effect, but 25 + minimally invasive vitreoretinal surgery can effectively reduce intraoperative complications and postoperative hypotony, with higher safety Sex.